Last modified: December 1, 2019 compiled over 100 examples of unsubstantiated health and disease-treatment claims made by Nerium distributors about the company’s products, such as being able to treat, cure, or alleviate the symptoms of depression, post-traumatic stress disorder, Alzheimer’s disease, Parkinson’s disease, psoriasis, eczema, acne, and rosacea. also compiled numerous examples of deceptive, atypical, and unsubstantiated income claims regarding the financial gains consumers will achieve by becoming distributors of Nerium.

As a result of these findings, sent a warning letter to Nerium on June 6, 2016 notifying it of’s findings and asking that the company remedy the deceptive marketing immediately. On June 14, 2016, the company informed that it was taking immediate action to address the deceptive claims at issue, including contacting its distributors, requesting the removal of deceptive claims, and educating its distributors about how to make proper claims about the products and business opportunity.

However, three weeks after receiving Nerium’s promising response, audited the original sampling of deceptive claims being made about Nerium’s products and business opportunity that it provided to the company, and found that the majority of the claims were still up on the Internet.

July 12, 2016 filed complaint letters with the Federal Trade Commission and Texas Attorney General urging them both to investigate the company and take appropriate enforcement action.

You can read’s full press release here


Was this article helpful?
Dislike 0 0 of 0 found this article helpful.
Views: 10

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.